查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2096949

伴侶動物診斷市場－2026-2032年全球市場預測

Companion Animal Diagnostics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，伴侶動物診斷市場將成長至 65.5 億美元，複合年成長率為 8.94%。

主要市場統計數據
基準年 2025 35.9億美元
預計年份：2026年 39億美元
預測年份 2032 65.5億美元
複合年成長率 (%) 8.94%

伴侶動物診斷市場執行摘要

隨著寵物照護、預防醫學和慢性病管理的融合，伴侶動物診斷正成為現代獸醫學的核心領域。犬、貓及其他伴侶動物的診斷檢測包括臨床化學、血液學、免疫學、分子診斷、尿液檢查、組織病理學、微生物學、影像學支援以及即時檢測。需求成長的促進因素包括：人們對通用感染疾病的認知不斷提高、寵物壽命延長、多個國家寵物保險的普及以及對循證獸醫決策日益成長的期望。獸醫不僅將診斷檢測用於確診疾病，還用於監測健康狀況、制定合理使用抗生素的指南、個人化治療以及支持內分泌、腎臟、肝臟、感染疾病、腫瘤和心血管代謝疾病的早期發現。該領域也受到寵物診療模式從一次性就診轉變為長期健康管理的影響，實驗室數據、電子健康記錄和連網診斷設備有助於更全面地了解臨床情況。因此，伴侶動物診斷正從單純的後勤部門臨床職能轉變為實現高品質照護、贏得寵物飼主信任、提高診所效率和加強公共衛生監管的策略基礎。

伴侶動物診斷領域的變革性變化

伴侶動物診斷領域正經歷一場變革，其驅動力來自臨床、技術和營運方面的變革。獸醫院擴大採用院內分析儀和快速即時診斷技術，以縮短檢測結果報告時間，並支援就診當日的治療決策。同時，外部實驗室對於複雜檢測、確診、病理檢查、高級分子檢測以及品管的高通量工作流程仍然至關重要。分子診斷技術，包括基於聚合酵素鏈鎖反應(PCR) 的檢測和基於定序的方法，正在增強對感染疾病、遺傳性疾病和新興病原體的檢測能力。同時，免疫檢測和基於生物標記的檢測組合正在拓展評估與發炎、器官功能、內分泌紊亂、心臟負荷和癌症相關的訊號的能力。數位化也是一項重大變革，實驗室資訊系統、電子健康記錄、遠端分診和雲端連接設備正在改善診所、檢查室和寵物飼主之間的資料共享。此外，該領域透過強調細菌培養、藥敏試驗和循證處方箋來解決抗生素抗藥性問題。這些變革正在創造一個比傳統「檢測和報告」模式更快、更協調、更具預防性且臨床整合度更高的診斷環境。

人工智慧對診斷醫學的累積影響

人工智慧正透過簡化工作流程、提供決策支援、識別模式以及提升預測性臨床洞察力，對伴侶動物的診斷產生累積影響。在診斷影像和數位病理學領域，人工智慧工具可以幫助識別異常情況、確定病例優先順序並規範觀察，但診斷和治療決策的責任仍然在於臨床醫生。在臨床實驗室醫學領域，人工智慧和機器學習有助於品管、識別異常情況、確定患者數據隨時間變化的趨勢，以及檢測與物種和品種相關的標準模式的細微偏差。人工智慧也透過分析感染疾病趨勢、季節性模式和地理叢集的總結診斷訊號，增強了疾病監測，這在通用和媒介傳播疾病中尤其重要。在獸醫醫院，人工智慧驅動的決策支援可以根據臨床症狀、年齡、品種、疫苗接種史、旅遊史和合併症來最佳化檢測選擇，從而可能減少漏診和不必要的檢測。然而，負責任的實施需要檢驗的資料集、透明的模型性能、網路安全措施、臨床醫生的監督，以及對因品種、物種、年齡和地區等因素造成的疾病流行偏差的考慮。人工智慧在伴侶動物診斷中的最大價值不在於取代獸醫的專業知識，而在於補充。

全球伴侶動物診斷的關鍵區域見解

在亞太地區，受都市區寵物飼養量增加、獸醫基礎設施改善以及預防保健意識增強的推動，中國、印度、日本、韓國、澳洲和東南亞的伴侶動物診斷領域正經歷強勁成長。該地區氣候多樣，易受病媒傳播，且高度重視通用動物感染疾病防控，加之對人畜共患病原體監測的需求，因此在感染疾病診斷領域也佔據著至關重要的地位。北美地區仍然是伴侶動物診斷領域最先進的地區之一，這得益於獸醫服務的高利用率、廣泛的實驗室和即時檢測服務、完善的健康管理計劃以及電子病歷與臨床工作流程的高度整合。在拉丁美洲，巴西和墨西哥是重要的成長中心，這主要得益於寵物飼養量的成長、中產階級在獸醫保健方面的支出以及動物醫院的現代化，儘管都市區之間的電子健康記錄資源獲取差距仍然是亟待解決的重大挑戰。在歐洲，診斷檢測技術已發展成熟，主要國家高度重視動物福利、合理使用抗生素、檢查室品質標準、預防醫學以及伴侶動物疾病監測。在中東，由於高階寵物護理的需求、獸醫院網路的擴張、伴侶動物進口量的增加以及都市區對伴侶動物健康的日益關注，診斷檢測的需求正在不斷成長。在非洲，各地區的情況差異很大，伴侶動物診斷技術的發展與整體獸醫能力建設、通用感染疾病意識的提高、狂犬病預防工作的開展以及主要大都會圈檢測服務覆蓋範圍的擴大同步進行。

來自領先的經濟和政策團體對伴侶動物診斷的見解。

在東南亞國協，都市化、寵物「人性化」以及私人獸醫服務的擴張推動了快速檢測、健康檢查、寄生蟲檢測和傳染病篩檢的使用，進一步提升了伴侶動物診斷的重要性。海灣合作理事會（GCC）國家對先進獸醫服務的需求日益成長。優質診斷服務、影像支援、與實驗室的合作以及專家轉診變得越來越重要，尤其是在都市區寵物護理領域。歐盟透過專注於動物健康、減少抗生素抗藥性、數據品質、檢測標準和跨境疾病監測的法規發揮關鍵作用，為循證診斷和負責任的檢測創造了有利環境。金磚國家（BRICS）是一個多元化但又極具影響力的集團，它們擁有大規模的伴侶動物數量，獸醫教育不斷發展，診斷技術的應用也日益普及，但同時也面臨著成本效益、基礎設施和區域可及性等挑戰。七國集團（G7）國家通常擁有較高的診斷技術成熟度，這得益於其先進的獸醫網路、某些市場較高的保險普及率、數位化臨床管理、實驗室認證體係以及飼主對預防性篩檢的高度接受度。北約成員國與北美和歐洲的先進獸醫體係高度重合，這些地區的伴侶動物診斷正透過高臨床標準、生物監測意識以及日益普及的數據驅動型疾病監測而不斷發展。在這些地區，最大的機會在於便捷的即時檢測、檢查室合作、獸醫教育以及支持預防性疾病、慢性病和感染疾病管理的診斷技術。

影響伴侶動物診斷技術普及的主要國家趨勢

美國在伴侶動物診斷技術的廣泛臨床應用方面處於主導，這得益於其龐大的獸醫醫院網路、便捷的實驗室以及在健康檢查、專科治療和臨床管理中日益普及的數位化工具。加拿大同樣重視預防醫學、實驗室品質和伴侶動物健康監測，這主要得益於其高寵物擁有率和強大的獸醫專業實力。墨西哥也取得了進展，這得益於都市區獸醫服務的擴展以及人們對傳染病檢查意識的提高。同時，巴西也因其龐大的寵物數量、私人獸醫服務的興起以及對檢查室診斷需求的不斷成長而顯得尤為重要。英國擁有成熟的獸醫體系，這得歸功於寵物保險、預防醫學和完善的臨床指南。德國、法國、義大利和西班牙等歐洲國家正在推廣先進診斷技術，日益關注慢性病監測、抗生素使用、寄生蟲學、媒介傳播疾病和檢查室品質。在俄羅斯，都市區寵物護理的成長和私人獸醫診所的擴張推動了需求，但區域間服務取得的差異仍然是一個重大挑戰。在中國，由於主要城市寵物擁有率的上升和對高品質獸醫服務需求的增加，獸醫診斷正在快速現代化。在印度，獸醫診斷正從基礎臨床檢測轉向更廣泛的診斷，尤其是在寵物護理意識和獸醫服務基礎設施不斷完善的大都會圈。日本擁有成熟的伴侶動物照護文化，由於寵物老化和對預防性篩檢的高需求，在老年寵物診斷領域佔據著尤為重要的地位。澳洲則充分利用其高寵物擁有率、對預防性獸醫護理的重視以及對感染疾病、寄生蟲病和生物安全相關疾病風險的高度認知等優勢。在韓國，隨著寵物「人性化」的不斷推進、專業獸醫服務的普及、人們對保險的興趣日益濃厚以及對數位健康的日益重視，診斷技術的應用正在不斷進步。

為伴侶動物診斷領域的領導者提供實用建議。

行業領導者應優先考慮能夠應對實際臨床挑戰的診斷解決方案：快速提供檢測結果、高分析可靠性、直覺的工作流程以及為獸醫提供可操作的解讀。擴大即時檢測範圍需要嚴格的品質保證、校準方案、員工培訓、外部品質控制以及清晰的參考檢查室驗證途徑。領導者應投資於整合數據生態系統，將分析儀器、實驗室資訊系統、電子健康記錄和客戶溝通平台連接起來，以支援寵物長期健康管理。產品開發應重點關注臨床負擔較重的領域，例如腎臟疾病、內分泌疾病、感染疾病、心臟病、胃腸道疾病、循環系統、寄生蟲疾病和抗生素使用。人工智慧工具應經過臨床檢驗，透明公開，並旨在支援獸醫決策，而不是創建不透明的自動化流程。區域策略應反映當地的疾病流行情況、獸醫基礎設施、財政能力、監管要求和語言需求。與獸醫教育工作者、專業組織和診斷培訓計畫合作，可以提高檢測的活用狀況和結果解讀的品質。此外，領導者還需要加強試劑、耗材和設備供應的穩定性，並確保聯網診斷平台的網路安全和資料隱私。

伴侶動物診斷分析的調查方法

本執行摘要採用系統的二手研究方法編寫，使用了公開且經過驗證的資料來源，包括獸醫文獻、同行評審期刊、動物衛生機構、監管出版刊物、獸醫專業指南、疾病檢驗數據、檢查室品管框架和公共衛生文件。分析重點關注伴侶動物研究途徑領域的實證資訊來源，包括技術採納、臨床應用、區域發展、人工智慧應用案例以及診斷工作流程的演變。研究成果透過獸醫服務、臨床實驗室醫學、即時檢測、分子診斷、免疫診斷、合理使用抗菌藥物、通用感染疾病監測和數位健康整合等主題的評估進行整合。區域、群體和國家層面的觀點是基於可觀察的指標進行解讀，例如獸醫基礎設施、寵物飼養趨勢、監管重點、臨床實踐成熟度、預防保健的採納以及感染疾病的重要性。本調查方法不涉及市場規模估算、市場佔有率、數值預測或特定供應商的定位。因此，我們獲得了定性和決策導向的觀點，旨在幫助更深入地了解策略規劃、內容定位和伴侶動物診斷生態系統。

結論：伴侶動物診斷是戰略獸醫學的促進者。

伴侶動物診斷正逐漸成為預防獸醫學的核心要素，能夠實現更早期的疾病檢測、更精準的治療、更完善的慢性病監測以及更有效的感染疾病控制。即時檢測、先進的診斷方法、分子診斷、數位連接和人工智慧正在重塑這一領域，所有這些都提高了診斷決策的速度和臨床價值。不同地區的趨勢有所不同，成熟市場強調綜合護理和品質標準，而新興市場則更關注可近性、可負擔性、獸醫基礎設施和傳染病篩檢。最佳的發展路徑在於將可靠的診斷科學與可操作的臨床工作流程、經過驗證的人工智慧輔助、負責任的數據管治以及幫助獸醫將檢測結果轉化為更佳治療效果的教育相結合。隨著寵物飼主對高品質、預防性和個人化護理的期望日益提高，伴侶動物診斷將繼續對獸醫實踐成果、動物福利、合理使用抗生素、通用感染疾病監測以及更廣泛的「同一健康」計劃至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 伴侶動物診斷市場：依產品/服務分類

  • 消耗品
    • 試劑
    • 檢測套組
  • 設備/分析儀
    • 臨床化學分析儀
    • 血液檢測設備
    • 免疫診斷分析儀
    • 分子診斷分析儀

第8章：伴侶動物診斷市場：依檢測類型分類

  • 血液學
    • 血液凝固檢查
    • 血液常規檢查（CBC）
  • 組織病理學
  • 診斷影像
    • 超音波檢查
    • X光
  • 分子診斷
    • DNA定序
    • PCR
  • 血清學

第9章：伴侶動物診斷市場：依動物類型分類

  • 鳥
  • 貓
  • 狗
  • 天竺鼠
  • 馬

第10章：伴侶動物診斷市場：依應用領域分類

  • 內分泌檢查
  • 基因檢測
  • 感染疾病診斷
  • 營養分析
  • 腫瘤學
  • 藥物監測
  • 毒性測試

第11章 伴侶動物診斷市場：依最終使用者分類

  • 院內檢測設施
    • 動物收容所
    • 寵物飼主
  • 研究所
  • 獸醫醫院和診所

第12章 伴侶動物診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：伴侶動物診斷市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 伴侶動物診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agrolabo SpA
  • Bio-Rad Laboratories, Inc.
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Demeditec Diagnostics GmbH
  • Eurofins Scientific SE
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Mars, Incorporated
  • Neogen Corporation
  • Nisseiken Co., Ltd
  • Qiagen NV
  • Randox Laboratories, Ltd.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • SKYER, Inc.
  • Skyla Corporation
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-AD517FAA89C5

The Companion Animal Diagnostics Market is projected to grow by USD 6.55 billion at a CAGR of 8.94% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.59 billion
Estimated Year [2026] USD 3.90 billion
Forecast Year [2032] USD 6.55 billion
CAGR (%) 8.94%

Companion Animal Diagnostics Executive Summary

Companion animal diagnostics is becoming a core pillar of modern veterinary care as pet ownership, preventive medicine, and chronic disease management converge. Diagnostic testing for dogs, cats, and other companion animals spans clinical chemistry, hematology, immunodiagnostics, molecular diagnostics, urinalysis, cytology, histopathology, microbiology, imaging support, and point-of-care testing. Demand is being shaped by rising awareness of zoonotic diseases, longer pet lifespans, growth in pet insurance adoption in several countries, and increasing expectations for evidence-based veterinary decisions. Veterinarians are using diagnostics not only to confirm disease but also to monitor wellness, guide antimicrobial stewardship, personalize treatment, and support early detection of endocrine, renal, hepatic, infectious, oncologic, and cardiometabolic conditions. The sector is also influenced by the shift from episodic sick visits to longitudinal pet health management, where laboratory data, digital medical records, and connected diagnostic devices help create a more complete clinical picture. As a result, companion animal diagnostics is moving from a back-office clinical function to a strategic enabler of quality care, client trust, clinic efficiency, and public health surveillance.

Transformative Shifts in the Companion Animal Diagnostics Landscape

The companion animal diagnostics landscape is undergoing transformative shifts driven by clinical, technological, and operational change. Veterinary practices are increasingly adopting in-clinic analyzers and rapid point-of-care diagnostics to shorten turnaround times and support same-visit treatment decisions, while reference laboratories remain essential for complex testing, confirmatory diagnostics, pathology, advanced molecular assays, and quality-controlled high-throughput workflows. Molecular diagnostics, including polymerase chain reaction-based testing and sequencing-enabled approaches, is strengthening detection of infectious diseases, inherited disorders, and emerging pathogens. At the same time, immunoassays and biomarker-based panels are expanding the ability to evaluate inflammation, organ function, endocrine disorders, cardiac stress, and cancer-associated signals. Digitalization is another major shift, with laboratory information systems, electronic medical records, tele-triage, and cloud-connected devices improving data continuity across clinics, laboratories, and pet owners. The sector is also responding to antimicrobial resistance concerns by emphasizing culture, susceptibility testing, and evidence-based prescribing. These changes are creating a diagnostics environment that is faster, more connected, more preventive, and more clinically integrated than the traditional test-and-report model.

Cumulative Impact of Artificial Intelligence on Diagnostic Care

Artificial intelligence is having a cumulative impact on companion animal diagnostics by improving workflow efficiency, decision support, pattern recognition, and predictive clinical insight. In diagnostic imaging and digital pathology, AI-enabled tools can assist in identifying abnormalities, prioritizing cases, and standardizing interpretation, while clinicians retain responsibility for diagnosis and treatment decisions. In laboratory medicine, AI and machine learning can support quality control, flag outlier results, identify trends across longitudinal patient data, and help detect subtle deviations from species- and breed-relevant reference patterns. AI is also strengthening syndromic surveillance by analyzing aggregated diagnostic signals for infectious disease trends, seasonal patterns, and geographic clusters, which is especially relevant for zoonotic and vector-borne diseases. In veterinary clinics, AI-driven decision support can help align test selection with clinical signs, age, breed, vaccination history, travel exposure, and comorbidities, potentially reducing missed diagnoses and unnecessary testing. However, responsible implementation requires validated datasets, transparent model performance, cybersecurity safeguards, clinician oversight, and attention to bias across breeds, species, ages, and regional disease prevalence. The greatest value of AI in companion animal diagnostics will come from augmenting veterinary expertise rather than replacing it.

Key Regional Insights Across Global Companion Animal Diagnostics

Asia-Pacific is experiencing strong momentum in companion animal diagnostics as urban pet ownership expands, veterinary infrastructure improves, and awareness of preventive care grows across China, India, Japan, South Korea, Australia, and Southeast Asia. The region is also highly relevant for infectious disease diagnostics due to diverse climates, vector exposure, companion animal rabies control priorities, and the need for surveillance of zoonotic pathogens. North America remains one of the most advanced regions for companion animal diagnostics, supported by high veterinary service utilization, broad availability of reference laboratories and point-of-care testing, established wellness programs, and strong integration of electronic medical records in clinical workflows. In Latin America, Brazil and Mexico are important growth centers as pet populations, middle-class spending on veterinary care, and clinic modernization increase, though access disparities between urban and rural areas remain a key consideration. Europe demonstrates mature adoption of diagnostic testing, with strong emphasis on animal welfare, antimicrobial stewardship, laboratory quality standards, preventive medicine, and companion animal disease surveillance across major countries. The Middle East is seeing rising demand linked to premium pet care, growing veterinary hospital networks, increased importation of companion animals, and greater attention to urban companion animal health. Africa presents a heterogeneous landscape, where companion animal diagnostics is developing alongside broader veterinary capacity-building, zoonotic disease awareness, rabies prevention initiatives, and expanding access to laboratory services in major metropolitan areas.

Key Economic and Policy Group Insights for Companion Animal Diagnostics

ASEAN countries are becoming increasingly important in companion animal diagnostics as urbanization, pet humanization, and expanding private veterinary services support greater use of rapid tests, wellness panels, parasitology, and infectious disease screening. The GCC is characterized by rising demand for advanced veterinary services, especially in urban pet care settings where premium diagnostics, imaging support, laboratory partnerships, and specialty referrals are gaining relevance. The European Union plays a critical role through its regulatory emphasis on animal health, antimicrobial resistance reduction, data quality, laboratory standards, and cross-border disease monitoring, creating a favorable environment for evidence-based diagnostics and responsible test utilization. BRICS countries represent a diverse but influential group, combining large companion animal populations, expanding veterinary education, and growing diagnostic adoption, while also facing affordability, infrastructure, and regional access challenges. G7 countries generally show high diagnostic maturity, supported by advanced veterinary networks, stronger insurance penetration in selected markets, digital practice management, laboratory accreditation practices, and greater client acceptance of preventive screening. NATO member countries overlap significantly with developed veterinary systems in North America and Europe, where companion animal diagnostics is shaped by high clinical standards, biosurveillance awareness, and increasing use of data-driven disease monitoring. Across these groups, the strongest opportunities are linked to accessible point-of-care testing, laboratory integration, practitioner education, and diagnostics that support preventive, chronic, and infectious disease management.

Key Country Insights Shaping Companion Animal Diagnostics Adoption

The United States leads in broad clinical adoption of companion animal diagnostics, supported by extensive veterinary hospital networks, reference laboratory access, wellness testing, specialty practices, and growing use of digital tools in practice management. Canada demonstrates a similar emphasis on preventive care, laboratory quality, and companion animal health monitoring, with demand shaped by high pet ownership and strong veterinary professionalism. Mexico is advancing through expanding urban veterinary services and rising awareness of infectious disease testing, while Brazil shows significant relevance due to its large pet population, increasing private veterinary care, and growing demand for laboratory-backed diagnosis. The United Kingdom has a mature veterinary care environment influenced by pet insurance, preventive medicine, and strong clinical guidelines. Germany, France, Italy, and Spain reflect advanced European diagnostic adoption, with growing attention to chronic disease monitoring, antimicrobial stewardship, parasitology, vector-borne diseases, and laboratory quality. Russia presents demand shaped by urban pet care growth and expanding private clinics, though regional access variation remains important. China is rapidly modernizing veterinary diagnostics as pet ownership rises in major cities and demand for premium veterinary care increases. India is progressing from basic clinical testing toward broader diagnostic use, particularly in metropolitan areas where pet care awareness and veterinary service capacity are expanding. Japan has a sophisticated companion animal care culture, with strong relevance for geriatric pet diagnostics due to aging pet populations and high demand for preventive screening. Australia benefits from high pet ownership, preventive veterinary engagement, and strong awareness of infectious, parasitic, and biosecurity-related disease risks. South Korea is seeing rising diagnostic adoption as pet humanization, specialty veterinary services, insurance interest, and digital health engagement continue to advance.

Actionable Recommendations for Companion Animal Diagnostics Leaders

Industry leaders should prioritize diagnostic solutions that address real clinical pain points: faster turnaround, high analytical reliability, intuitive workflows, and actionable interpretation for veterinarians. Expanding point-of-care testing should be balanced with strong quality assurance, calibration protocols, staff training, external proficiency practices, and clear pathways for confirmatory reference laboratory testing. Leaders should invest in integrated data ecosystems that connect analyzers, laboratory information systems, electronic medical records, and client communication platforms to support longitudinal pet health management. Product development should focus on high-burden clinical areas, including renal disease, endocrine disorders, infectious diseases, oncology, cardiology, gastrointestinal disease, dermatology, parasitology, and antimicrobial stewardship. AI-enabled tools should be clinically validated, transparent, and designed to support veterinarian decision-making rather than create opaque automation. Regional strategies should reflect local disease prevalence, veterinary infrastructure, affordability, regulatory expectations, and language needs. Partnerships with veterinary educators, professional associations, and diagnostic training programs can improve test utilization and interpretation quality. Leaders should also strengthen supply resilience for reagents, consumables, and instruments, while ensuring cybersecurity and data privacy for connected diagnostic platforms.

Research Methodology for Companion Animal Diagnostics Analysis

This executive summary is developed through a structured secondary research approach using publicly available, verified sources such as veterinary medical literature, peer-reviewed journals, animal health authorities, regulatory publications, professional veterinary guidelines, disease surveillance resources, laboratory quality frameworks, and public health documentation. The analysis emphasizes evidence-backed trends in companion animal diagnostics, including technological adoption, clinical applications, regional development, artificial intelligence use cases, and diagnostic workflow evolution. Insights are synthesized through thematic assessment of veterinary care delivery, laboratory medicine, point-of-care testing, molecular diagnostics, immunodiagnostics, antimicrobial stewardship, zoonotic disease monitoring, and digital health integration. Regional, group, and country perspectives are interpreted based on observable indicators such as veterinary infrastructure, pet ownership trends, regulatory emphasis, clinical practice maturity, preventive care adoption, and infectious disease relevance. The methodology avoids market sizing, market share, numerical forecasting, and vendor-specific positioning. The result is a qualitative, decision-oriented view designed to support strategic planning, content positioning, and informed understanding of the companion animal diagnostics ecosystem.

Conclusion: Companion Animal Diagnostics as a Strategic Veterinary Care Enabler

Companion animal diagnostics is evolving into a central component of proactive veterinary medicine, enabling earlier detection, more precise treatment, better chronic disease monitoring, and stronger infectious disease control. The field is being reshaped by point-of-care testing, advanced laboratory assays, molecular diagnostics, digital connectivity, and artificial intelligence, all of which are improving the speed and clinical value of diagnostic decision-making. Regional dynamics vary, with mature markets emphasizing integrated care and quality standards, while emerging markets focus on access, affordability, veterinary capacity, and infectious disease screening. The strongest path forward lies in combining reliable diagnostic science with practical clinic workflows, validated AI support, responsible data governance, and education that helps veterinarians translate results into better outcomes. As pet owners increasingly expect high-quality, preventive, and personalized care, companion animal diagnostics will remain essential to veterinary practice performance, animal welfare, antimicrobial stewardship, zoonotic disease monitoring, and the broader One Health agenda.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Companion Animal Diagnostics Market, by Offering

  • 7.1. Introduction
  • 7.2. Consumables
    • 7.2.1. Reagents
    • 7.2.2. Test kits
  • 7.3. Instruments/Analyzers
    • 7.3.1. Clinical chemistry analyzers
    • 7.3.2. Hematology analyzers
    • 7.3.3. Immunodiagnostic analyzers
    • 7.3.4. Molecular diagnostic analyzers

8. Companion Animal Diagnostics Market, by Test Type

  • 8.1. Introduction
  • 8.2. Hematology
    • 8.2.1. Blood Clotting Test
    • 8.2.2. Complete Blood Count (CBC)
  • 8.3. Histopathology
  • 8.4. Imaging
    • 8.4.1. Ultrasound
    • 8.4.2. X-Rays
  • 8.5. Molecular Diagnostics
    • 8.5.1. DNA Sequencing
    • 8.5.2. PCR
  • 8.6. Serology

9. Companion Animal Diagnostics Market, by Animal Type

  • 9.1. Introduction
  • 9.2. Birds
  • 9.3. Cats
  • 9.4. Dogs
  • 9.5. Guinea pigs
  • 9.6. Horses

10. Companion Animal Diagnostics Market, by Application

  • 10.1. Introduction
  • 10.2. Endocrinology Testing
  • 10.3. Genetic Testing
  • 10.4. Infectious Disease Diagnostics
  • 10.5. Nutritional Analysis
  • 10.6. Oncology
  • 10.7. Therapeutic Drug Monitoring
  • 10.8. Toxicology Testing

11. Companion Animal Diagnostics Market, by End-User

  • 11.1. Introduction
  • 11.2. In-House Testing Facilities
    • 11.2.1. Animal Shelters
    • 11.2.2. Pet Owners
  • 11.3. Research Laboratories
  • 11.4. Veterinary Hospitals & Clinics

12. Companion Animal Diagnostics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Companion Animal Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Companion Animal Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agrolabo S.p.A.
  • 16.2. Bio-Rad Laboratories, Inc.
  • 16.3. Biogal Galed Labs
  • 16.4. BioMerieux S.A.
  • 16.5. BioNote, Inc.
  • 16.6. Demeditec Diagnostics GmbH
  • 16.7. Eurofins Scientific SE
  • 16.8. Fassisi GmbH
  • 16.9. FUJIFILM Holdings Corporation
  • 16.10. IDEXX Laboratories, Inc.
  • 16.11. IDvet
  • 16.12. Mars, Incorporated
  • 16.13. Neogen Corporation
  • 16.14. Nisseiken Co., Ltd
  • 16.15. Qiagen N.V.
  • 16.16. Randox Laboratories, Ltd.
  • 16.17. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 16.18. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 16.19. SKYER, Inc.
  • 16.20. Skyla Corporation
  • 16.21. Thermo Fisher Scientific Inc.
  • 16.22. Vimian Group AB
  • 16.23. Virbac S.A.
  • 16.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INSTRUMENTS/ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INSTRUMENTS/ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSTRUMENTS/ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEMATOLOGY ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEMATOLOGY ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEMATOLOGY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNODIAGNOSTIC ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNODIAGNOSTIC ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNODIAGNOSTIC ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MOLECULAR DIAGNOSTIC ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MOLECULAR DIAGNOSTIC ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MOLECULAR DIAGNOSTIC ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD CLOTTING TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD CLOTTING TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD CLOTTING TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPLETE BLOOD COUNT (CBC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMPLETE BLOOD COUNT (CBC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPLETE BLOOD COUNT (CBC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HISTOPATHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HISTOPATHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HISTOPATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL X-RAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL X-RAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL X-RAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SEROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SEROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SEROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIRDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GUINEA PIGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GUINEA PIGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GUINEA PIGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOCRINOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOCRINOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOCRINOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NUTRITIONAL ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NUTRITIONAL ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NUTRITIONAL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IN-HOUSE TESTING FACILITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IN-HOUSE TESTING FACILITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IN-HOUSE TESTING FACILITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL SHELTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL SHELTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL SHELTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 202. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 204. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 205. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 209. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 240. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 245. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 250. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 252. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 253. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 254. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 257. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 330. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 334. GERMANY COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE